SCHEMBL14374015

SCHEMBL14374015

COC(=O)CSc1cc(O)c(OC)cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ MAPT P10636 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ TP53 P04637 1/20 0.48
▸ POLB P06746 2/20 0.45
▸ GLA P06280 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ HMGCR P04035 3/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ PRNP P04156 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14374020 0.76 KIF11 (0.40) HSD17B10ALDH1A1MAPTHPGDKDM4E
SCHEMBL8147119 0.75 MAPT (0.64) HSD17B10ALDH1A1MAPTHPGDTP53
SCHEMBL14374013 0.75 FASN (0.41) HSD17B10ALDH1A1MAPTHPGDTP53
SCHEMBL8147865 0.74 MAPT (0.62) HSD17B10ALDH1A1MAPTHPGDTP53
SCHEMBL11800701 0.73 HSD17B10 (0.59) HSD17B10ALDH1A1MAPTHPGDTP53
SCHEMBL8144828 0.71 HSD17B10 (0.66) HSD17B10ALDH1A1MAPTHPGDTP53
SCHEMBL9126180 0.71 HMGCR (0.50) HSD17B10ALDH1A1MAPTHPGDKDM4E
SCHEMBL14347051 0.70 ALOX5 (0.61) CYP3A4CYP2C9CYP2C19CYP1A2KMT2A
SCHEMBL8145291 0.70 HSD17B10 (0.51) HSD17B10ALDH1A1MAPTHPGDTP53
SCHEMBL69624 0.70 MAOB (0.59) HSD17B10ALDH1A1MAPTHPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070286906-A1 DIHYDROBENZOQUINONE COMPOUNDS HUTCHISON MEDIPHARMA ENTERPRISES LIMITED (BS) 2007-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070286906-A1 DIHYDROBENZOQUINONE COMPOUNDS NQO1, SDHA, SDHB HSD17B10 470/4885ALDH1A1 122/4885MAPT 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback